Clinical trial
The Role of Inhalations of Tranexamic Acid in Patients With Hemoptysis
NCT01496196 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Inhalations of Tranexamic Acid in Patients With Hemoptysis
- Lead sponsor
- Meir Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2012
- Completion date
- February 29, 2016
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemoptisis